list of glp 1 receptor agonists Classification currently available glucagon-like peptide-1 GLP-1 Receptor Agonists Show Promise

In a 10-week clinical trial, a daily dose of 20 mg oral semaglutide achieved a steady-state plasma concentration of 30 nM, and when daily dose of oral semaglutide was increased to 40 mg, the semaglutide plasma concentration reached about 60 nM (102), which was over a thousand times higher than the EC50 of semaglutide for GLP-1R activation (95)

Novel signal transduction and peptide specificity of glucagonlike peptide receptor in 3T3L1 adipocytes

Similarly the weight loss seen with Exenatide and some other early GLP-1 drugs was thought too limited to win approval for the treatment of obesity (Gilbert, Rosenthal, March 2024)

95% CI, 0.421.17)

SIRT1/HSF1/HSP Pathway is Essential for Exenatide-Alleviated, Lipid-Induced Hepatic Endoplasmic Reticulum Stress